657. Kroutil W, Genzel Y, Pietzsch M, Syldatk C, Faber K (1998) J. Biotechnol. 61: 143
658. Svaving J, de Bont JAM (1998) Enzyme Microb. Technol. 22: 19
659. Archer IVJ (1997) Tetrahedron 53: 15617
660. Weijers CAGM, de Bont JAM (1999) J. Mol. Catal. B 6: 199
661. Orru RVA, Archelas A, Furstoss R, Faber K (1999) Adv. Biochem. Eng. Biotechnol. 63: 145
662. Faber K, Mischitz M, Kroutil W (1996) Acta Chem. Scand. 50: 249
663. de Vries EJ, Janssen DB (2003) Curr. Opin. Chem. Biol. 14: 414.
664. Bala N, Chimni SS (2010) Tetrahedron: Asymm. 21: 2879.
665. Reetz MT, Bocola M, Wang L-W, Sanchis J, Cronin A, Arand M, Zhou J, Archelas A,
Bottalla A-L, Naworyta A, Mowbray SL (2009) J. Am. Chem. Soc. 131: 7334.
666. Kotik M, Archelas A, Wohlgemuth R (2012) Curr. Org. Chem. 16: 451.
667. Orru RVA, Faber K (1999) Curr. Opinion Chem. Biol. 3: 16
668. Botes AL, Steenkamp JA, Letloenyane MZ, van Dyk MS (1998) Biotechnol. Lett. 20: 427;
the microorganism used in this study (Chryseomonas luteola) causes inner ear infections in
infants and belongs to safety Class II.
669. Weijers CAGM (1997) Tetrahedron Asymmetry 8: 639
670. Botes AL, Weijers CAGM, van Dyk MS (1998) Biotechnol. Lett. 20: 421
671. Weijers CAGM, Botes AL, van Dyk MS, de Bont JAM (1998) Tetrahedron Asymmetry 9:
467
672. Morisseau C, Nellaiah H, Archelas A, Furstoss R, Baratti JC (1997) Enzyme Microb.
Technol. 20: 446
673. Spelberg JHL, Rink R, Kellogg RM, Janssen DB (1998) Tetrahedron Asymmetry 9: 459
674. Grogan G, Rippe C, Willetts A (1997) J. Mol. Catal. B 3: 253
675. Pedragosa-Moreau S, Archelas A, Furstoss R (1996) Tetrahedron 52: 4593
676. Mischitz M, Kroutil W, Wandel U, Faber K (1995) Tetrahedron Asymmetry 6: 1261
677. Moussou P, Archelas A, Furstoss R (1998) Tetrahedron 54: 1563
678. Kroutil W, Mischitz M, Plachota P, Faber K (1996) Tetrahedron Lett. 37: 8379
679. Mischitz M, Faber K (1996) Synlett. 978
680. Archer IVJ, Leak DJ, Widdowson DA (1996) Tetrahedron Lett. 37: 8819
681. Steinreiber A, Mayer SF, Saf R, Faber K (2001) Tetrahedron Asymmetry 12: 1519
682. Steinreiber A, Mayer SF, Faber K (2001) Synthesis 2035.
683. Edegger K, Mayer SF, Steinreiber A, Faber K (2004)Tetrahedron 60: 583.
684. Archer IVJ, Leak DJ, Widdowson DA (1996) Tetrahedron Lett. 37: 8819.
685. Imai K, Marumo S, Mori K (1974) J. Am. Chem. Soc. 96: 5925
686. Pedragosa-Moreau S, Archelas A, Furstoss R (1993) J. Org. Chem. 58: 5533
687. Orru RVA, Mayer SF, Kroutil W, Faber K (1998) Tetrahedron 54: 859
688. Kroutil W, Mischitz M, Faber K (1997) J. Chem. Soc., Perkin Trans. 1, 3629
689. Goswami A, Totleben MJ, Singh AK, Patel RN (1999) Tetrahedron: Asymm. 10: 3167.
690. Kong X-D, Ma Q, Zhou J, Zeng B-B, Xu J-H (2014) Angew. Chem. Int. Ed. 53: 6641.
691. Legras JL, Chuzel G, Arnaud A, Galzy P (1990) World Microbiol. Biotechnol. 6: 83
692. Solomonson LP (1981) Cyanide as a metabolic inhibitor. In: Vennesland B et al. (eds)
Cyanide in Biology. Academic Press, London, p 11
693. Legras JL, Jory M, Arnaud A, Galzy P (1990) Appl. Microbiol. Biotechnol. 33: 529
694. Jallageas JC (1980) Adv. Biochem. Eng. 14: 1
695. Meth-Cohn O, Wang MX (1995) Tetrahedron Lett. 36: 9561
696. Hjort CM, Godtfredsen SE, Emborg C (1990) J. Chem. Technol. Biotechnol. 48: 217
697. Thompson LA, Knowles CJ, Linton EA, Wyatt JM (1988) Chem. Brit. 900
698. Nagasawa T, Yamada H (1989) Trends Biotechnol. 7: 153
699. Asano Y (2002) J. Biotechnol. 94: 65.
700. Wang M-X (2011) Topics Organomet. Chem. 36: 105.
701. Prasad S, Bhalla TC (2010) Biotechnol. Adv. 28: 725.
702. Arnaud A, Galzy P, Jallageas JC (1976) Folia Microbiol. 21: 178
703. Nagasawa T, Takeuchi K, Yamada H (1988) Biochem. Biophys. Res. Commun. 155: 1008
278
2 Biocatalytic Applications
Précédent

- 288/442

Suivant